Welcome to the Global HIV Clinical Forum website!
The second edition of the Global HIV Clinical Forum on Integrase Inhibitors was held on 22 July, 2017 in Paris (France), preceding the IAS2017.
The meeting was an incredible success with almost 85 attendees visiting the meeting!
The Global HIV Clinical Forum focused entirely on Integrase Inhibitors as Integrase Inhibitors are rapidly gaining a central role in the routine care of HIV infected individuals. The HIV Clinical Forum meetings aim at enhancing the clinical skills and research capabilities of HIV healthcare professionals in regard to this unique class of antiretroviral drugs.
Meeting materials such as abstracts, presentations and webcasts have been made available on InfectiousDiseasesOnline (given that speakers have provided their permission).
We look forward to welcoming you to the next Global HIV Clinical Forum on Integrase Inhibitors in 2018, preceding the 22nd International AIDS Conference (AIDS2018) in Amsterdam, The Netherlands!
On behalf of the Global HIV Clinical Forum Program Chairs, we would like to thank ViiV Healthcare for their unrestricted education grant, as well as Mylan for their generous contribution. We would also like to thank our endorsers for their invaluable support of the meeting and of course a big thank you to all of our participants in making this meeting into a huge success!
We look forward to seeing you again in July 2018, in Amsterdam, The Netherlands!
Bernhard Haas, MD
Presentation materials can also be found on www.infectiousdiseasesonline.com
Saturday 22 July
|9.00h||Welcome & Introductions|
|9.15h||Basic Science of Integrase Inhibitors – Recent Advances
Francois Clavel, MD
Hopital Saint Louis, Paris, France
|9.45h||Resistance Characteristics of Integrase Inhibitors
Charlotte Charpentier, PharmD, PhD
Hôpital Bichat-claude Bernard, Paris, France
|10.15h||Clinical Case – Transmitted/Acquired Resistance Related
Michelle Moorhouse, MBBCh
Wits RHI, Johannesburg, South Africa
| COFFEE BREAK
|11.30h||Potential role of integrase inhibitors in resource-limited settings
University of Cape Town, Cape Town, South Africa
|12.00h||Clinical Pharmacology related considerations
University of Liverpool, Liverpool, United Kingdom
|14.15h||Optimal Use of Integrase Inhibitors in Women
Sharon Walmsley, MSc, MD, FRCPC
University of Toronto, Toronto, Canada
|14.45h||Pediatric use of Integrase Inhibitors
Mark Cotton, MD
Stellenbosch University, Tygerberg, South Africa
| COFFEE BREAK
|16.30h||The Role of Integrase Inhibitors during HIV prevention
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
|17.00h||Clinical Case – Reduced Drug Regimen
Fundación Huésped, Buenos Aires, Argentina
|17.30h||Optimizing Clinical Utility of Integrase Inhibitors
Chelsea and Westminster Hospital, London, United Kingdom
The 2nd Global HIV Forum meeting : Integrase Inhibitors was generously supported by an unrestricted educational grant from ViiV Healthcare.
Corporate Support Opportunities 2018
Financial backing from the corporate community will help us deliver an impactful and essential meeting experience. This collaboration plays a vital role for both the organizational and the scientific success of the program.
Your financial support will help advance the field significantly by providing healthcare professionals with a platform to present findings, discuss conclusions, and create strategies for the future.
Show your commitment to the cause and get in touch with us for a tailored support package. Please contact Alice Posthumus-Plantinga at email@example.com or call +31 6 224 82 179.
The 2nd Global HIV Clinical Forum was endorsed by the following organizations. Their support and collaboration play a key role to this meeting’s success and we are proud and honoured to call each and every one of them partners. Interested in endorsing our 2018 meeting? Get in touch with us if you want your organization to be part of this meeting, at firstname.lastname@example.org.